Cancer Drugs Remain Hot Targets.
Estimates of future growth in the oncology market, a predicted increase of 11% per year in sales, and the need to expand drug-development pipelines to sustain profits have been driving up the value of corporate mergers, such as Pfizer's purchase of Medivation for $14 billion.
D000969:Antinematodal Agents / Q000191:economics*; D004345:Drug Industry / Q000191:economics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics
D000969:Antinematodal Agents